Other languages Aptevo Therapeutics Inc.

Equities

APVO

US03835L3069

Market Closed - Nasdaq Other stock markets 21:00:00 01/05/2024 BST			5-day change	1st Jan Change
0.96 ^USD	+35.08%		+40.64%	-87.95%

04-11	US Equity Markets Close Mixed After March Producer Price Inflation Data	MT
04-11	Top Midday Decliners	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

US Equity Markets Close Mixed After March Producer Price Inflation Data	04-11
Top Midday Decliners	04-11
Aptevo Therapeutics Inc. Provides Pipeline Update	04-10
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4	03-07
Aptevo Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05
Aptevo Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14
Aptevo Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Aptevo Therapeutics Prices Offering of 8 Million Shares, Expects $5 Million Gross Proceeds	02/08/23
Aptevo Therapeutics Inc. Announces Positive Duration of Remission Data from Phase 1B Expansion Trial Evaluating the Bispecific APVO436 for AML	18/07/23
Aptevo Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
XOMA Acquires Commercial Payment, Portion of Milestone Rights to Ixinity For $9.6 Million	30/03/23
Aptevo Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23
Aptevo Therapeutics Inc. Appoints Jeffrey G. Lamothe to Executive Vice President, Chief Operating Officer	07/03/23
Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG.APV-527 in Phase 1 Clinical Trial	13/02/23
Aptevo Therapeutics Inc. Files Provisional Patent for Fifth Bispecific Antibody APVO711, Intended for the Treatment of Solid Tumors	09/01/23
Sector Update: Health Care Stocks Carried Higher with Broader Markets	12/12/22
Sector Update: Health Care	12/12/22
Top Midday Gainers	12/12/22
Aptevo Therapeutics Says Leukemia Combination Therapy Showed Clinical Benefit in Early Stage Study	12/12/22
Wall Street Set to Open Higher as Investors Await Inflation Data, Fed Rate Decision in Coming Days	12/12/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aptevo Therapeutics Inc.

Equities

APVO

US03835L3069

Other languages

Filters